Key Highlights from ESMO 2024 – Shaping the Future of Clinical Oncology

In this special edition of CancerSpeak, CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan (Social Media Editor for CANCER), Dr. Jason Luke (Melanoma and Skin Section Editor for CANCER), and patient advocate Deborah Collyar to discuss key takeaways from the European Society for Medical Oncology (ESMO) 2024 Congress. From advances in melanoma and immunotherapy, to the role social media plays during clinical oncology meetings and in patient advocacy, this episode explores emerging developments that have the potential to impact clinical oncology practice and patient care.

Learn more about Free Format submission with CANCER: https://bit.ly/CANCERFreeFormatSubmission

Read an introductory editorial about Direct to CANCER: https://bit.ly/DirectToCANCER

Music by Ivymusic, obtained from Pixabay.